View in EDS HTML Full Text PDF Full Text

Dual targeting of VEGFR2 and CSF1R with SYHA1813 confers novel strategy for treating both BRAF wild-type and mutant melanoma.

Saved in:
Bibliographic Details
Title: Dual targeting of VEGFR2 and CSF1R with SYHA1813 confers novel strategy for treating both BRAF wild-type and mutant melanoma.
Authors: Shi, Wenhao1 (AUTHOR), Tang, Haotian1,2 (AUTHOR), Tong, Linjiang2 (AUTHOR), Song, Peiran1 (AUTHOR), Huang, Yuqing1 (AUTHOR), Wan, Zhipeng1 (AUTHOR), Huang, Gege1 (AUTHOR), Liu, Qiupei1,3 (AUTHOR), Zhan, Zhengsheng4 (AUTHOR), Zhou, Yu1 (AUTHOR), Li, Yuantong1 (AUTHOR), Wen, Jiaxin1,2 (AUTHOR), Tang, Bencan3 (AUTHOR), Duan, Wenhu4 (AUTHOR), Ding, Jian2 (AUTHOR), Li, Xiaorui5 (AUTHOR) xiaorui_li@126.com, Xie, Hua1,2 (AUTHOR) hxie@simm.ac.cn
Source: Cancer Cell International. 7/25/2025, Vol. 25 Issue 1, p1-12. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 186909364
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Dual targeting of VEGFR2 and CSF1R with SYHA1813 confers novel strategy for treating both BRAF wild-type and mutant melanoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Shi%2C+Wenhao%22">Shi, Wenhao</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tang%2C+Haotian%22">Tang, Haotian</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tong%2C+Linjiang%22">Tong, Linjiang</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Song%2C+Peiran%22">Song, Peiran</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Huang%2C+Yuqing%22">Huang, Yuqing</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wan%2C+Zhipeng%22">Wan, Zhipeng</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Huang%2C+Gege%22">Huang, Gege</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+Qiupei%22">Liu, Qiupei</searchLink><relatesTo>1,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhan%2C+Zhengsheng%22">Zhan, Zhengsheng</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhou%2C+Yu%22">Zhou, Yu</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Yuantong%22">Li, Yuantong</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wen%2C+Jiaxin%22">Wen, Jiaxin</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tang%2C+Bencan%22">Tang, Bencan</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Duan%2C+Wenhu%22">Duan, Wenhu</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ding%2C+Jian%22">Ding, Jian</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Xiaorui%22">Li, Xiaorui</searchLink><relatesTo>5</relatesTo> (AUTHOR)<i> xiaorui_li@126.com</i><br /><searchLink fieldCode="AR" term="%22Xie%2C+Hua%22">Xie, Hua</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> hxie@simm.ac.cn</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Cancer+Cell+International%22">Cancer Cell International</searchLink>. 7/25/2025, Vol. 25 Issue 1, p1-12. 12p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=186909364
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s12935-025-03902-y
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 12
        StartPage: 1
    Titles:
      – TitleFull: Dual targeting of VEGFR2 and CSF1R with SYHA1813 confers novel strategy for treating both BRAF wild-type and mutant melanoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Shi, Wenhao
      – PersonEntity:
          Name:
            NameFull: Tang, Haotian
      – PersonEntity:
          Name:
            NameFull: Tong, Linjiang
      – PersonEntity:
          Name:
            NameFull: Song, Peiran
      – PersonEntity:
          Name:
            NameFull: Huang, Yuqing
      – PersonEntity:
          Name:
            NameFull: Wan, Zhipeng
      – PersonEntity:
          Name:
            NameFull: Huang, Gege
      – PersonEntity:
          Name:
            NameFull: Liu, Qiupei
      – PersonEntity:
          Name:
            NameFull: Zhan, Zhengsheng
      – PersonEntity:
          Name:
            NameFull: Zhou, Yu
      – PersonEntity:
          Name:
            NameFull: Li, Yuantong
      – PersonEntity:
          Name:
            NameFull: Wen, Jiaxin
      – PersonEntity:
          Name:
            NameFull: Tang, Bencan
      – PersonEntity:
          Name:
            NameFull: Duan, Wenhu
      – PersonEntity:
          Name:
            NameFull: Ding, Jian
      – PersonEntity:
          Name:
            NameFull: Li, Xiaorui
      – PersonEntity:
          Name:
            NameFull: Xie, Hua
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 25
              M: 07
              Text: 7/25/2025
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 14752867
          Numbering:
            – Type: volume
              Value: 25
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Cancer Cell International
              Type: main
ResultId 1